Epigenetic Targeted Anti-Cancer Drugs: An Unfolding Story THE BOUMBER ARTICLE REVIEWED

被引：0
|
作者：
Marks, Paul A. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
ONCOLOGY-NEW YORK | 2011年 / 25卷 / 03期
关键词：
HISTONE DEACETYLASE INHIBITORS; CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：231 / 235
页数：2
相关论文
共 50 条
  • [41] Targeted Anti-Cancer Therapies for Renal Cancer
    Robert J. Amato
    Jaroslaw Jac
    Drugs, 2006, 66 : 2161 - 2171
  • [42] Mitochondrially targeted anti-cancer agents
    Biasutto, Lucia
    Dong, Lan-Feng
    Zoratti, Mario
    Neuzil, Jiri
    MITOCHONDRION, 2010, 10 (06) : 670 - 681
  • [43] Targeted anti-cancer therapy in the elderly
    Gonsalves, Wilson
    Ganti, Apar Kishor
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (03) : 227 - 242
  • [44] Epigenetic reprogramming in anti-cancer drug resistance
    Tan, Jing
    CANCER SCIENCE, 2024, 115 : 402 - 402
  • [45] Are isothiocyanates potential anti-cancer drugs?
    Wu, Xiang
    Zhou, Qing-hua
    Xu, Ke
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (05) : 501 - 512
  • [46] MCAB TARGETING ANTI-CANCER DRUGS
    BALDWIN, RW
    BRITISH JOURNAL OF CANCER, 1984, 50 (04) : 561 - 562
  • [47] PREDICTION OF RESPONSE TO ANTI-CANCER DRUGS
    FAVRE, R
    PIGNON, T
    MAROTIA, L
    SEITZ, JF
    DELPERO, JR
    GUERINEL, G
    CARCASSONNE, Y
    PRESSE MEDICALE, 1983, 12 (45): : 2875 - 2879
  • [48] EFFECT OF ANTI-CANCER DRUGS ON COMPLEMENT
    MCKENZIE, D
    CLOSKY, J
    HETRICK, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1970, 11 : 54 - &
  • [49] FORMULATION OF INVESTIGATIONAL ANTI-CANCER DRUGS
    REPTA, AJ
    PHARMACY INTERNATIONAL, 1981, 2 (07): : ABS2 - ABS2
  • [50] THE RISING COST OF ANTI-CANCER DRUGS
    Karikios, D. J.
    Schofield, D.
    Salkeld, G.
    Mann, K. P.
    Trotman, J.
    Stockler, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E35 - E35
12345